Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology International"
DOI: 10.1007/s00296-021-04980-7
Abstract: To compare the clinical and laboratory findings of multisystem inflammatory syndrome in children (MIS-C), patients with Kawasaki disease (KD) and with macrophage activating syndrome due to systemic juvenile idiopathic arthritis (sJIA-MAS) on real-life data. Patients… read more here.
Keywords: inflammatory syndrome; sjia mas; patients mis; multisystem inflammatory ... See more keywords
OP0197 Evaluation of a dosing regimen for tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.2386
Abstract: Background Tocilizumab (TCZ) is approved for the treatment of systemic juvenile idiopathic arthritis (sJIA) based on clinical trials in patients (pts) ≥2 years of age. This study (NP25737) is the first for a biologic in… read more here.
Keywords: none declared; age; years age; sjia ... See more keywords
P127 Lung disease in systemic JIA: an emerging problem linked with young age and anti-IL-1/IL-6
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-ewrr2019.115
Abstract: Career situation of first and presenting author Post-doctoral fellow. Introduction The advent of anti-IL-1/IL-6 therapies transformed the management of systemic juvenile idiopathic arthritis (sJIA), a debilitating childhood inflammatory condition. However, concurrent with practice change, pediatric… read more here.
Keywords: none declared; sjia; lung disease; disease ... See more keywords
AB0996 APPLICATION OF YAMAGUCHI CRITERIA FOR CLASSIFICATION OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.3487
Abstract: Background The ILAR criteria require the presence of arthritis to classify a patient as having sJIA. The sJIA patients prior to the onset of arthritis (suspected sJIA) appeared clinically similar to patients fulfilling the ILAR… read more here.
Keywords: yamaguchi criteria; ilar criteria; sjia; arthritis ... See more keywords
THU0513 WHOLE BLOOD CELLS FROM PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) IN CLINICAL INACTIVE DISEASE DISPLAY A DYSREGULATED RESPONSE TO TLR-4 STIMULATION
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.6895
Abstract: Background: Systemic juvenile idiopathic arthritis (sJIA) is a polygenic autoinflammatory disease. Innate immune mechanisms appear to play a central role in the pathogenesis of the disease. Nevertheless, a better understanding of the pathophysiology of sJIA… read more here.
Keywords: none declared; sjia patients; disease; sjia ... See more keywords
Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232112757
Abstract: Systemic juvenile idiopathic arthritis (sJIA) and its complication, macrophage activation syndrome (sJIA-MAS), are rare but sometimes very serious or even critical diseases of childhood that can occasionally be characterized by nonspecific clinical signs and symptoms… read more here.
Keywords: macrophage activation; activation syndrome; sjia; systemic juvenile ... See more keywords